About
Healionics is addressing the critical need for safer, more reliable means of bloodstream access to perform dialysis in patients with kidney failure. Our STARgraft vascular graft (synthetic blood vessel) is designed to resist the problems of occlusion and infection suffered by current devices. We also have an exciting product pipeline based on our platform STAR® biomaterial, which has a unique ability to prevent two serious problems that affect all implantable devices: scarring and infection. The company is currently conducting human studies of STARgraft and has 36 patents issued or pending.
Technologies
Outlook
Google Cloud Hosting
Mobile Friendly
Nginx
WordPress.org
Remote
Sisense
AI
Webmail
Domo
KNIME
Keywords
biotechnology
life sciences
biocompatibility
bioresistance
tissue regeneration
infection resistance
fda breakthrough device
healthcare equipment & supplies
biointegration
sphere templated angiogenic regeneration
implantable devices
medical equipment and supplies manufacturing
vascular graft
medical device
tissue healing
biomaterials
angiogenesis
biointegration technology
star platform
medical devices
nanobiotechnology
wound healing scaffolds
dialysis access
regenerative medicine
stargraft
biomaterial scaffold
investigational device
porous biomaterials
vascular access devices
b2b
Company Information
-
Employees 10
-
Founded 2007
-
Annual Revenue $4000000
-
Total Funding $34433115
Location
2121 N 35th St, Seattle, Washington, United States, 98103-9103
